14. Importance of Diverse Research Participation

The initial lepodisiran trial included relatively few Black participants, even though this group has higher rates of elevated Lp(a). Researchers acknowledge this gap and are expanding enrollment of Black patients in ongoing phase 3 studies. This effort aims to make the results more representative and ensure the therapy’s effectiveness across all populations.
Read more at American Family Physician.